PMID: 9185137Jul 1, 1997Paper

Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
K G Kristinsson

Abstract

Penicillin-resistant and multi-resistant pneumococci have spread globally and reached high prevalence in many countries. Antimicrobial use is considered a major driving force for resistance, although the influence in the community has not been as clearly demonstrated. Other risk factors may be important, and only with a clear understanding of the risk factors can effective control measures be introduced. The main habitat of the pneumococcus is the nasopharynx of children. Carriage increases from birth and is maximal at pre-school age. Antimicrobial use in children is likely to have a significant influence on the susceptibility of pneumococci. Most studies looking for risk factors for resistance in pneumococci have identified antimicrobial use as a risk factor, especially the following aspects: ongoing, recent, repeated, frequent, and prophylactic antibiotic use. The effect of individual classes of antimicrobials has not been studied in detail but use of beta-lactam antibiotics and trimethoprim-sulpha has been associated with increased risk. Other risk factors are young age, nosocomial acquisition, prior hospitalization, and HIV infection. Day-care centers can facilitate the spread of resistant pneumococci and an Icelandic study...Continue Reading

References

Oct 5, 1978·The New England Journal of Medicine·M R JacobsR Austrian
Jul 11, 1975·The Journal of Infectious Diseases·J O HendleyJ M Gwaltney
Jun 27, 1992·Lancet·K G KristinssonO Steingrímsson
Dec 1, 1992·The Journal of Infectious Diseases·M R ReichlerR O Walton
Nov 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S V Nielsen, J Henrichsen
Apr 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M Musher
Jun 1, 1992·The Journal of Infectious Diseases·G AnianssonC Svanborg
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P C Appelbaum
Jan 1, 1991·The Journal of Hospital Infection·K D Allen
Dec 1, 1991·The Journal of Antimicrobial Chemotherapy·F BaqueroE Loza
Nov 21, 1991·The New England Journal of Medicine·C V Broome, R F Breiman
Apr 1, 1991·The Journal of Pediatrics·E R WaldC Byers
Apr 1, 1990·Clinical Microbiology Reviews·K P Klugman
Oct 1, 1988·Epidemiology and Infection·D Hansman, S Morris
Aug 1, 1987·European Journal of Clinical Microbiology·P C Appelbaum
Jul 1, 1986·The Journal of Antimicrobial Chemotherapy·H C NeuP Labthavikul
Sep 1, 1965·The American Journal of the Medical Sciences·J W KislakM Finland
Jan 28, 1971·The New England Journal of Medicine·D HansmanR Douglas
Jun 10, 1982·The New England Journal of Medicine·F W HendersonF W Denny
Nov 1, 1983·Reviews of Infectious Diseases·J E McGowan
Dec 14, 1995·The New England Journal of Medicine·G J Annas
Aug 24, 1995·The New England Journal of Medicine·J HofmannR F Breiman
May 1, 1995·The Pediatric Infectious Disease Journal·G H McCracken
Mar 1, 1995·Infection and Immunity·D R CundellE I Tuomanen
Mar 1, 1994·The Pediatric Infectious Disease Journal·G AnianssonH Sabharwal
Sep 1, 1995·The Pediatric Infectious Disease Journal·J S DuchinJ A Elliott
Oct 1, 1995·Journal of Clinical Microbiology·J Henrichsen
Feb 1, 1996·The Journal of Infectious Diseases·M R ReichlerR F Breiman
Jan 17, 1996·JAMA : the Journal of the American Medical Association·D B JerniganR F Breiman
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·M M ParísG H McCracken
Oct 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J HedlundG Källenius
Dec 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D CundellE I Tuomanen
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P FairchokG W Fischer
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J P BédosB Régnier
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P E KimC E Wright

❮ Previous
Next ❯

Citations

Apr 15, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Nowosiad, S Giedrys-Kalemba
Apr 7, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Raymond OppongUNKNOWN GRACE-01 Study Team
Nov 30, 2000·Current Infectious Disease Reports·R L Wientzen, C Barbey-Morel
Jul 14, 1999·The American Journal of Medicine·S BentD Grady
Sep 24, 2002·Lancet·UNKNOWN Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
Nov 20, 1998·The Journal of Infection·K D Allen
Sep 21, 2000·International Journal of Pediatric Otorhinolaryngology·A B MagnúsdóttirA Melhus
Apr 17, 2003·International Journal of Pediatric Otorhinolaryngology·Margaretha Foglé-HanssonAnn Hermansson
Aug 26, 1999·International Journal of Antimicrobial Agents·J M Cristino
Jul 27, 1999·International Journal of Antimicrobial Agents·J VerhoefR Jones
Nov 11, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·D H Spach, D Black
Oct 6, 1999·Current Opinion in Microbiology·D Guillemot
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J AustinR M Anderson
Mar 27, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SoewignjoS Arjoso
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B R Levin
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jörg J Ruhe, Rodrigo Hasbun
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jörg J RuheRodrigo Hasbun
Jul 10, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·R B RobertsUNKNOWN PRP Collaborative Study Group
Oct 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vilhjalmur A ArasonKarl G Kristinsson
Jul 3, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·K EkdahlK Persson
Nov 11, 2009·The Journal of Antimicrobial Chemotherapy·M SundqvistG Kahlmeter
Apr 27, 2000·The Pediatric Infectious Disease Journal·R Dagan
Jul 18, 2003·The Pediatric Infectious Disease Journal·Brigittte DunaisPierre Dellamonica
May 5, 2010·Antimicrobial Agents and Chemotherapy·Emilio Pérez-TralleroUNKNOWN Spanish Surveillance Group for Respiratory Pathogens
Oct 2, 2002·Journal of Clinical Microbiology·Raquel Sá-LeãoHermínia de Lencastre
Jul 9, 2003·BMC Medical Informatics and Decision Making·Sara SilvaJonas Almeida
Feb 27, 2003·Emerging Infectious Diseases·Cheryl R SteinMeera Kelley
Nov 12, 2003·Emerging Infectious Diseases·Andrea SmithDavid Fisman
May 5, 2010·The American Journal of Tropical Medicine and Hygiene·Henry D KalterBillie Velapatiño
Apr 14, 2011·Fukushima Journal of Medical Science·Ayumi MatsumotoMitsuaki Hosoya
Feb 23, 2012·Fukushima Journal of Medical Science·Ayumi MatsumotoMitsuaki Hosoya
Dec 7, 2013·The Journal of Antimicrobial Chemotherapy·M Á Hjálmarsdóttir, K G Kristinsson
Nov 2, 2012·Scandinavian Journal of Infectious Diseases·Susann SkovbjergChristina Åhrén
May 16, 2000·Scandinavian Journal of Primary Health Care·H Z DiederichsenJ Kragstrup

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
K G Kristinsson
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S E BeekmannG V Doern
Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
D L Klein
© 2021 Meta ULC. All rights reserved